← FDA Warning Letters

Fagron Group B.V.

FDA Warning Letter · 2022-06-28 · Division of Pharmaceutical Quality Operations III

Letter

Company
Fagron Group B.V.
Posted Date
2022-06-28
Letter Issue Date
2022-06-14
Issuing Office
Division of Pharmaceutical Quality Operations III

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown